Early Evaluation of the Beacon Aqueous Microshunt in Patients Refractory to Drug Therapy in the European Union

NCT03634319 · clinicaltrials.gov ↗
NA
Phase
TERMINATED
Status
10
Enrollment
INDUSTRY
Sponsor class

Stopped Significant risks (e.g., infection, endothelial cell loss) and high rate of channel plugging associated with product use.

Conditions

Interventions

Sponsor

MicroOptx